Cutera, Inc. (CUTR)
After hours:
| Previous close | 1.8200 |
| Open | 1.8500 |
| Bid | 1.6200 x 100 |
| Ask | 1.6700 x 400 |
| Day's range | 1.6250 - 1.8600 |
| 52-week range | 1.2800 - 21.4100 |
| Volume | |
| Avg. volume | 868,907 |
| Market cap | 33.32M |
| Beta (5Y monthly) | 1.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.9100 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.33 |
Business WireCutera® Announces New Survey Data During Acne Awareness Month
BRISBANE, Calif., June 13, 2024--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June’s Acne Awareness Month. The findings highlight the impact of acne on individuals and emphasize the substantial role of novel treatments like AviClear®, the first FDA-cleared energy-based device for the long-term treatment of mild, moderate, and severe inflammatory acne, in improving quality of life.
Business WireCutera® Appoints Jeryl L. Hilleman to Board of Directors
BRISBANE, Calif., June 10, 2024--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that Jeryl "Jeri" Hilleman will join its Board of Directors, effective July 12, 2024.
Business WireCutera® Announces AviClear® Investor Webinar
BRISBANE, Calif., June 07, 2024--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will hold an investor webinar at 11 a.m. PDT on June 20, 2024, to present an overview of AviClear, the first FDA-cleared energy device for the long-term treatment of mild, moderate, and severe inflammatory acne. The webinar will include a review of clinical data, market opportunity, future clinical studies, and real-world user experience.
